Mabion S.A. Logo

Mabion S.A.

Global CDMO providing end-to-end services for developing and manufacturing complex biologic drugs.

MAB | WAR

Overview

Corporate Details

ISIN(s):
PLMBION00016 (+1 more)
LEI:
259400KG5JVQPPZL6X53
Country:
Poland
Address:
Konstantynów Łódzki GEN. MARIANA LANGIEWICZA 60, 95-050 Konstantynów Łódzki
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Mabion S.A. is a biopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing end-to-end services to pharmaceutical and biotech companies globally. The company specializes in the development, analytics, and manufacturing of complex biologic drugs. Mabion leverages advanced statistical methodologies, such as Design of Experiments (DoE), to optimize bioprocesses, enhance product quality, and ensure regulatory compliance. This data-driven approach supports accelerated development timelines and efficient, robust manufacturing for its partners, demonstrated through its involvement in large-scale production projects for biologics and vaccine components.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-24 21:15
Board/Management Information
Powołanie Prezesa Zarządu Spółki - Content (EN)
English 3.0 KB
2025-09-24 21:15
Board/Management Information
Powołanie Prezesa Zarządu Spółki - Content (PL)
Polish 2.8 KB
2025-09-19 17:14
Board/Management Information
Zmiana w składzie Zarządu Spółki - Content (EN)
English 805 bytes
2025-09-19 17:14
Board/Management Information
Zmiana w składzie Zarządu Spółki - Content (PL)
Polish 414 bytes
2025-09-12 15:05
Board/Management Information
Zmiana w składzie Zarządu Spółki - Content (EN)
English 812 bytes
2025-09-12 15:05
Board/Management Information
Zmiana w składzie Zarządu Spółki - Content (PL)
Polish 551 bytes
2025-09-05 17:55
Board/Management Information
Zmiany w składzie Zarządu Spółki - Content (PL)
Polish 5.8 KB
2025-08-18 16:17
Related Party Transaction
Rozszerzenie współpracy z Instituto De Biologia Molecular Do Paraná - IBMP popr…
Polish 2.2 KB
2025-07-29 17:59
Registration Form
Tekst Jednolitego Statutu Spółki
Polish 274.9 KB
2025-07-29 17:59
Registration Form
Przyjęcie tekstu jednolitego Statutu Spółki - Content (PL)
Polish 744 bytes
2025-07-23 17:36
Post-Annual General Meeting Information
Treść postanowień Statutu Mabion S.A. zmienionych uchwałą nr 3/VII/2025 Nadzwyc…
Polish 191.6 KB
2025-07-23 17:36
Registration Form
Rejestracja zmiany Statutu Spółki - Content (PL)
Polish 691 bytes
2025-07-14 13:32
Report Publication Announcement
Zmiana terminów publikacji raportów okresowych Spółki - Content (PL)
Polish 686 bytes
2025-07-11 14:48
Regulatory News Service
Zawiadomienie_korekta
Polish 82.0 KB
2025-07-11 14:48
Regulatory News Service
Zawiadomienie
Polish 81.4 KB

Automate Your Workflow. Get a real-time feed of all Mabion S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Mabion S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea 034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan 4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden CINPHA
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway CRNA
CJ Bioscience Logo
Develops microbiome therapeutics for oncology & IBD using an AI drug discovery platform.
South Korea 311690
CKD Bio Corp. Logo
Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.
South Korea 063160
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Compugen Ltd. Logo
Uses AI to discover and develop novel antibody immunotherapies for hard-to-treat cancers.
Israel CGEN
CORESTEMCHEMON Inc. Logo
Develops stem cell therapies & provides preclinical CRO services to pharma & biotech.
South Korea 166480

Talk to a Data Expert

Have a question? We'll get back to you promptly.